Best Blue Chip Stocks

Compare the best blue-chip stocks. Blue chip companies are very large, well-established companies that usually have a market capitalization in the billions. INTEL (INTC), BOEING (BA) and Johnson & Johnson (JNJ) are some of the most trending stocks in the Best Blue sector.

Compare up to 10 stocks

RESET ALL

INTC BA JNJ BRK.B MMM ABBV T CI MSFT

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Market Cap	P/E Ratio	Dividend Yield	Sector
INTC Intel	$20.92	78.54M	xxxxxxxxxxxxx	1 Buy 22 Hold 6 Sell Hold	$90.23B	-5.63	2.39%	Technology
BA Boeing	$153.93	8.18M	xxxxxxxxxxxxx	15 Buy 6 Hold 2 Sell Moderate Buy	$115.07B	-11.93	―	Industrials
JNJ Johnson & Johnson	$149.31	8.39M	xxxxxxxxxxxxx	6 Buy 8 Hold 0 Sell Moderate Buy	$359.48B	24.68	3.29%	Healthcare
BRK.B Berkshire Hathaway B	$470.50	3.27M	xxxxxxxxxxxxx	1 Buy 0 Hold 0 Sell Moderate Buy	$1.01T	9.50	―	Financial
MMM 3M	$133.11	1.91M	xxxxxxxxxxxxx	5 Buy 3 Hold 2 Sell Moderate Buy	$72.49B	16.81	2.71%	Industrials
ABBV AbbVie	$176.19	4.84M	xxxxxxxxxxxxx	13 Buy 7 Hold 0 Sell Moderate Buy	$311.35B	61.45	3.52%	Healthcare
T AT&T	$23.88	34.22M	xxxxxxxxxxxxx	12 Buy 4 Hold 0 Sell Strong Buy	$171.35B	19.41	4.65%	Communication Services
CI Cigna	$317.81	1.75M	xxxxxxxxxxxxx	12 Buy 2 Hold 0 Sell Strong Buy	$88.40B	29.98	1.71%	Healthcare
MSFT Microsoft	$443.57	18.82M	xxxxxxxxxxxxx	26 Buy 3 Hold 0 Sell Strong Buy	$3.30T	36.61	0.69%	Technology

Performance Comparison

INTC

Intel

20.92

-21.22

-50.36%

Boeing

153.93

-90.77

-37.09%

JNJ

Johnson & Johnson

149.31

-0.37

-0.25%

BRK.B

Berkshire Hathaway B

470.50

117.42

33.26%

MMM

133.11

49.58

59.36%

ABBV

AbbVie

176.19

32.17

22.34%

AT&T

23.88

7.94

49.81%

Cigna

317.81

63.19

24.82%

MSFT

Microsoft

443.57

72.12

19.42%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Blue Chip Stocks Latest News

AbbVie announces updated results from Phase 1b/2 EPCORE NHL-2 trial

AbbVie (ABBV) announced updated results from the Phase 1b/2 EPCORE NHL-2 trial evaluating fixed-duration investigational epcoritamab, a CD3xCD20...

1h ago

ABBV

Amazon (AMZN) Says It Is Not Seeing Enough Demand for AMD’s AI Chips

Shares of chipmaker AMD ($AMD) fell on Friday after an executive at tech and e-commerce giant Amazon ($AMZN)...

2d ago

AMD

IBM

UnitedHealth (UNH) Hits Dow Jones Hard after CEO’s Assassination

The Dow Jones Industrial Average is taking a beating on Friday with United Health shares weighing on the index. ...

2d ago

Investors Rotate Back into Magnificent 7 Stocks, including Amazon (AMZN) and Microsoft

The Magnificent 7 stocks are back. After months of trading sideways or slumping, the mega-cap tech stocks collectively...

2d ago

AAPL

AMZN

Intel’s (NASDAQ:INTC) New Turnaround Plan

Originally, former CEO Pat Gelsinger was brought in to turn around chipmaker Intel ($INTC). However, the company apparently...

2d ago

ASML

INTC

Boeing (NYSE:BA) Back-Burners Employee Surveillance Plan

While aerospace company Boeing’s ($BA) recent plans to cut costs made some sense, particularly in light of the...

2d ago

J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital

RBC Capital analyst Brian Abrahams notes that the clinicaltrials.gov listing for Johnson & Johnson’s (JNJ) second MDD Phase...

2d ago

JNJ

NMRA

U.S. Jobs Report Unlikely to Delay December Interest Rate Cut

The U.S. Employment Situation Summary for November is out and jobs increased 227,000 while unemployment came in at...

2d ago

HP Enterprise, Ulta Beauty report quarterly beats: Morning Buzz

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists....

2d ago

OpenAI Is Hopeful a Corporate Change Will Unlock Profits

OpenAI is hoping to hang on to Microsoft’s funding as it seeks to alter its corporate structure concerning profits. ...

2d ago

FNF

MSFT

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Blue Chip Stocks

Boeing

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Assigned

2024-12-06

INTC

Intel

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-12-05

MSFT

Microsoft

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Assigned

2024-12-05

AT&T

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-12-05

ABBV

AbbVie

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Downgraded

2024-12-04

MMM

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-11-24

JNJ

Johnson & Johnson

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-11-19

Cigna

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-11-19

BRK.B

Berkshire Hathaway B

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-11-04

INTC

Intel

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-12-05

All Ratings >

Most Recent Earnings of Blue Chip Stocks

INTC

Intel

Oct 31, 2024

Sep 01, 2024

-0.02 / -0.46

0.54

Boeing

Oct 23, 2024

Sep 01, 2024

-10.36 / -10.44

-0.47

JNJ

Johnson & Johnson

Oct 15, 2024

Sep 01, 2024

2.21 / 2.42

2.29

BRK.B

Berkshire Hathaway B

Nov 02, 2024

Sep 01, 2024

4.89 / 4.68

3.911

MMM

Oct 22, 2024

Sep 01, 2024

1.90 / 1.98

2.023

ABBV

AbbVie

Oct 30, 2024

Sep 01, 2024

2.92 / 3.00

2.79

AT&T

Oct 23, 2024

Sep 01, 2024

0.57 / 0.60

0.54

Cigna

Oct 31, 2024

Sep 01, 2024

7.23 / 7.51

6.79

MSFT

Microsoft

Oct 30, 2024

Sep 01, 2024

3.10 / 3.30

2.93

Blue Chip Stocks - FAQ

Which Blue Chip stocks have a "Strong Buy" analyst rating?

These Blue Chip stocks currently have a "Strong Buy" analyst rating consensus:

AT&T - Strong Buy, based on 16 analyst ratings, 12 Buy, 4 Hold, and 0 Sell.

Cigna - Strong Buy, based on 14 analyst ratings, 12 Buy, 2 Hold, and 0 Sell.

Microsoft - Strong Buy, based on 29 analyst ratings, 26 Buy, 3 Hold, and 0 Sell.

Are Blue Chip stocks overpriced?

Intel's stock price is currently $20.92, and its average 12-month price target is $24.43.

Boeing's stock price is currently $153.93, and its average 12-month price target is $193.38.

Johnson & Johnson's stock price is currently $149.31, and its average 12-month price target is $177.75.

Berkshire Hathaway B's stock price is currently $470.50, and its average 12-month price target is $531.00.

3M's stock price is currently $133.11, and its average 12-month price target is $151.67.

AbbVie's stock price is currently $176.19, and its average 12-month price target is $203.94.

AT&T's stock price is currently $23.88, and its average 12-month price target is $25.87.

Cigna's stock price is currently $317.81, and its average 12-month price target is $397.38.

Microsoft's stock price is currently $443.57, and its average 12-month price target is $497.36.

Which Blue Chip stocks pay dividends?

Intel does not currently pay dividends.

Boeing does not currently pay dividends.

Johnson & Johnson does not currently pay dividends.

Berkshire Hathaway B does not currently pay dividends.

3M does not currently pay dividends.

AbbVie currently pays a dividend of $1.64 which represents an annual dividend yield of 3.52%. AbbVie's next Ex-dividend date is January 15, 2025 and its next payout date is February 14, 2025.

AT&T does not currently pay dividends.

Cigna does not currently pay dividends.

Microsoft currently pays a dividend of $0.83 which represents an annual dividend yield of 0.69%. Microsoft's next Ex-dividend date is February 20, 2025 and its next payout date is March 13, 2025.